hospital covid-19 patient

Covid-19: What’s working in coronavirus treatments and what isn’t

Reading now: 526
www.livemint.com

“Toci": Two arthritis drugs that previously failed in treating Covid-19 — Roche Holding AG’s tocilizumab and Sanofi-Regeneron Pharmaceuticals Inc.’s sarilumab — are now showing a meaningful effect in helping reduce the burden of disease in some patients.

It seems that when the drugs are used is key. The latest data comes from a trial involving patients who were treated within 24 hours of needing hospital care in an intensive care unit.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA